Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

6.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Structure and Function of Platelets01:18

Structure and Function of Platelets

6.7K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
6.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adaption of the plasmin generation assay to enhance sensitivity to plasminogen activator inhibitor-1 and establishment of sex-specific reference values in human plasma.

Research and practice in thrombosis and haemostasis·2026
Same author

Single-domain antibodies to reverse the effects of factor Xa inhibitors on coagulation tests.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Fibrin-bound thrombin determines clot structure and blood thrombogenicity in normofibrinogenemia and dysfibrinogenemia.

Haematologica·2026
Same author

Factor XII locking in (for contact activation through disulfide control).

Journal of thrombosis and haemostasis : JTH·2026
Same author

Thrombin generation and thrombin dynamics are associated with recurrent venous thromboembolism after anticoagulation withdrawal.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Related Experiment Video

Updated: Apr 23, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

21.5K

Endocannabinoids control platelet activation and limit aggregate formation under flow.

Valentina De Angelis1, Arnold C Koekman1, Cees Weeterings1

  • 1Department of Clinical Chemistry and Haematology, Utrecht University Medical Center, Utrecht, The Netherlands.

Plos One
|September 30, 2014
PubMed
Summary

The endocannabinoid anandamide inhibits platelet activation and aggregation. Cannabis sativa consumption also impairs platelet function, suggesting potential antithrombotic applications.

More Related Videos

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

2.0K
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

10.8K

Related Experiment Videos

Last Updated: Apr 23, 2026

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

21.5K
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

2.0K
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

10.8K

Area of Science:

  • * Endocrinology and Hematology: Investigating the interplay between the endocannabinoid system and platelet physiology.

Background:

  • * The endocannabinoid system's role in regulating immune cells is established, but its impact on platelet function remains debated.
  • * Endocannabinoid receptors have been identified on circulating platelets, yet their specific contribution to platelet activation is unclear.

Purpose of the Study:

  • * To elucidate the role of endocannabinoids in modulating platelet function.
  • * To investigate the effects of anandamide on platelet activation markers and aggregate formation in vitro.
  • * To assess the in vivo impact of Cannabis sativa consumption on platelet activity.

Main Methods:

  • * In vitro studies using anandamide to assess platelet aggregation, degranulation, calcium signaling, and Syk phosphorylation.
  • * Analysis of platelet spreading, fibrinogen binding, and aggregate formation under flow conditions.
  • * Ex vivo assessment of platelet function in human volunteers following Cannabis sativa consumption.

Main Results:

  • * Anandamide significantly inhibited platelet aggregation and α-granule release induced by various agonists, except for thrombin receptor activation.
  • * Anandamide impaired collagen-induced calcium mobilization and Syk phosphorylation, reducing platelet spreading and aggregate formation.
  • * Ex vivo analysis revealed impaired platelet aggregation and aggregate formation in individuals who consumed Cannabis sativa.

Conclusions:

  • * Endocannabinoid receptor agonists demonstrably reduce platelet activation and aggregate formation.
  • * Findings suggest a novel regulatory pathway for platelet function involving endocannabinoids.
  • * This research may inform the development of new antithrombotic therapies.